These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 4593129

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined radiotherapy and chemotherapy for treatment of unresectable and or metastatic cancer.
    Glenn EH, Cole D, Wunderlich HO.
    Int J Clin Pharmacol; 1974 Jan; 9(1):37-40. PubMed ID: 4593128
    [No Abstract] [Full Text] [Related]

  • 7. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW, Martz G, Senn HJ, Obrecht P, Alberto P, Melchert F.
    Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
    Lee JM, Abeloff MD, Lenhard RE, Baker RR.
    Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
    [No Abstract] [Full Text] [Related]

  • 12. [Combined cytostatic treatment of solid tumours with cyclophosphamide (Endoxan), vincristine, methylaminopterin (Methotrexate) and 5-fluorouracil].
    Brincker H.
    Ugeskr Laeger; 1971 May 14; 133(19):926-9. PubMed ID: 5559763
    [No Abstract] [Full Text] [Related]

  • 13. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F, Alberto P, Jungi F, Brunner K, Martz G.
    Eur J Cancer (1965); 1980 May 14; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract] [Full Text] [Related]

  • 14. [Sequential chemotherapy based on the hypothesis of a circadian rhythm of tumor proliferation].
    Focan C.
    Nouv Presse Med; 1975 Nov 08; 4(38):2709-12. PubMed ID: 1105421
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
    Heuson JC, Sylvester R, Engelsman E.
    Eur J Cancer (1965); 1980 Nov 08; Suppl 1():113-7. PubMed ID: 7032920
    [No Abstract] [Full Text] [Related]

  • 17. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
    Levitt SH, Potish RA.
    Cancer Clin Trials; 1981 Nov 08; 4(4):363-9. PubMed ID: 7032731
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy using cyclophosphamide, vincristine, methotrexate, 5-fluorouracil, and prednisone in solid tumors.
    Bearden JD, Coltman CA, Moon TE, Costanzi JJ, Saiki JH, Balcerzak SP, Rivkin SE, Morrison FS, Lane M, Spigel SC.
    Cancer; 1977 Jan 08; 39(1):21-6. PubMed ID: 832235
    [Abstract] [Full Text] [Related]

  • 19. Surgical adjuvant trials in the United States.
    Rozencweig M, Von Hoff DD, Allegra JC, Muggia FM.
    Eur J Cancer (1965); 1980 Jan 08; Suppl 1():173-7. PubMed ID: 7032929
    [No Abstract] [Full Text] [Related]

  • 20. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT.
    Ugeskr Laeger; 1973 Jun 18; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.